Who is sponsoring NCT04899648?

NCT04899648 is sponsored by University of Washington.

What drugs are being tested in NCT04899648?

Interventions in NCT04899648: Behavioral Intervention Group.

What condition does NCT04899648 study?

NCT04899648 studies Hypertension, Dietary Modification, Health Behavior.

Is NCT04899648 still recruiting?

NCT04899648 is currently status unknown. Last updated 26 May 2021.

Last reviewed 2021-05-26 · How we verify

NCT04899648

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Hypertension Prevention Program, Implementation and Scale up- a Hybrid Effectiveness Implementation Study

Status unknown NA Last updated 26 May 2021

What this trial tests

NA trial testing Behavioral Intervention Group in Hypertension in 500 participants. Status unknown.

Timeline

30 May 2021

Primary endpoint
30 December 2021

30 December 2021

Quick facts

Lead sponsor	University of Washington
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	prevention
Enrollment	500
Start date	30 May 2021
Primary completion	30 December 2021
Estimated completion	30 December 2021

Drugs / interventions tested

Behavioral Intervention Group

Conditions studied

Hypertension — all drugs for Hypertension →
Dietary Modification — all drugs for Dietary Modification →
Health Behavior — all drugs for Health Behavior →

Sponsor

University of Washington

Who can join

Adults 18 to 60, any sex, with Hypertension or Dietary Modification. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is an effectiveness-implementation study to assess the effectiveness of a peer-led multi-component lifestyle program that will aim to lower BP among pre-hypertensive individuals in Nepal. The program will aim to encourage weight loss, improve diet (using a DASH diet), lower sodium intake, encourage only moderate alcohol intake among drinkers, and encourage more physical activity through peers.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Behavioral Intervention Group

Trials testing the same drug.

NCT03914469 — MOTIVATE: Moving to Improve Outcomes for Older Adults · NA · terminated
NCT03896035 — Improving Outcomes for Older Veterans With Chronic Back Pain and Depression · NA · completed

Other recruiting trials for Hypertension

Currently open trials in the same condition.

NCT07413159 — The "Check, Monitor, Control Hypertension" Study is a 24-month Randomized Trial in Houston Targeting African Americans A · NA · recruiting
NCT07361276 — Observational Study That Will Evaluate Treatment Patterns in the Management of Hypertension in the Public Primary Care S · recruiting
NCT07238556 — A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors · NA · recruiting
NCT07238400 — Cardiac Effects of Mineralocorticoid Receptor Antagonism After Preeclampsia · Phase 2 · recruiting
NCT07135505 — Early Time-Restricted Eating in Older Adults With Hypertension · NA · recruiting

Other University of Washington trials

Trials by the same sponsor.

NCT07430852 — Inherited and Environmental Risks Acting on Body Weight · NA · not yet recruiting
NCT07466498 — Estrogen to Improve Quality of Life for Men With Newly Diagnosed or Recurrent Metastatic Hormone Sensitive Prostate Canc · Phase 2 · not yet recruiting
NCT06422299 — Developing and Testing an Online Intervention for Alcohol and Cannabis Misuse and Healthy Relationship Skills Among Youn · NA · not yet recruiting
NCT07322341 — SX-682 and Atezolizumab for the Treatment of Advanced or Metastatic, Recurrent Non-small Cell Lung Cancer · Phase 2 · not yet recruiting
NCT07332351 — Neoadjuvant Intravesical Nadofaragene Firadenovec With Gemcitabine, Cisplatin and Durvalumab for the Treatment of Muscle · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04899648 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Washington
Last refreshed: 26 May 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04899648.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing